Chris Holly

Dr. Chris Holly is a life sciences patent attorney partnering with emerging companies and venture capital funds seeking to create and monetize disruptive innovation. His practice spans a wide spectrum of technological fields, with a core focus on biotechnology, synthetic biology, microbiology, cell therapy, agriculture and food innovation.

Chris works closely with emerging companies to protect and monetize cutting-edge technologies through strategic patent portfolio development. His goal is to craft intellectual property (IP) strategies that not only secure strong exclusivity but also support critical business milestones – whether it is raising capital, achieving a successful acquisition, preparing for an initial public offering or launching commercially. By aligning patent strategy with business objectives, Chris helps translate complex science into scalable, investor-ready assets that unlock long-term value.

Chris is a member of the Fellows of the American Bar Foundation, an honorary society recognizing distinguished attorneys, judges, law faculty and legal scholars worldwide.